Genomics

Dataset Information

Phase 1 Trial Combining Neoadjuvant Chemotherapy with Chemokine Modulatory Regimen for Triple Negative Breast Cancer


ABSTRACT: Phase 1 Trial Combining Neoadjuvant Chemotherapy with Chemokine Modulatory Regimen for Triple Negative Breast Cancer

PROVIDER: PRJNA1084787 | ENA |

REPOSITORIES: ENA